Colorectal Cancer

The Pharmacy Times® Colorectal Cancer Resource Center is a comprehensive resource for clinical news and expert insights on cancers that start in the colon or the rectum.

Latest News

AI depiction of colorectal cancer | Image Credit: © Ruby Stock - stock.adobe.com
The FDA Approves Sotorasib With Panitumumab for Treatment of Patients with KRAS G12C-Mutated Metastatic Colorectal Cancer

January 17th 2025

Data from the CodeBreaK 300 trial supported the FDA's approval.

Cancer Prevention and Screening Updates: A Pharmacist Primer
Updates in Cancer Prevention and Screening for 2025: A Pharmacist Primer

January 12th 2025

FDA, Fast Track Designation, Colorectal Cancer, Oncology | Image Credit: © Grandbrothers | stock.adobe.com
FDA Grants Fast Trask Designation to Invikafusp Alfa for Advanced Colorectal Cancer

January 10th 2025

Colorectal cancer cells under microscope | Image Credit: © Navaporn - stock.adobe.com
Encorafenib With Cetuximab and mFOLFOX6 Receives Accelerated Approval for Patients With Metastatic Colorectal Cancer

December 20th 2024

Depiction of colorectal cancer tumor growth Image Credit: © Dr_Microbe - stock.adobe.com
Chronic Inflammation Driven by Diet May Contribute to Colorectal Cancer, Study Finds

December 18th 2024

Latest CME Events & Activities

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...

2.0 Credits / Human Trafficking, Law

View More

Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

1.0 Credit / Law, Pain Management, Opioids

View More

More News

The Role of the Specialty Pharmacist in Treating Colorectal Cancer

The Role of the Specialty Pharmacist in Treating Colorectal Cancer

Emily Bintrim, PharmD Candidate;Jonathan Ogurchak, PharmD, CSP
April 16th 2020

Pharmacists are a rich resource, not only in the management of colorectal cancer, but in every aspect of health care.

Read More

FDA Approves Encorafenib Plus Cetuximab Therapy For Metastatic Colorectal Cancer Treatment

FDA Approves Encorafenib Plus Cetuximab Therapy For Metastatic Colorectal Cancer Treatment

April 9th 2020

The FDA has approved encorafenib in combination with cetuximab for the treatment of adult patients with metastatic colorectal cancer with a BRAF V600E mutation after prior therapy.

Read More

Exercise Can Benefit Patients Undergoing Treatment for Metastatic Colon Cancer

Exercise Can Benefit Patients Undergoing Treatment for Metastatic Colon Cancer

August 23rd 2019

Moderate physical activity may improve progression-free survival and reduce treatment-related adverse effects in patients undergoing chemotherapy for advanced colorectal cancer.

Read More

Report Shows Higher-Than-Expected Cancer Screening, Poorer Outcomes in Oldest Age Group

Report Shows Higher-Than-Expected Cancer Screening, Poorer Outcomes in Oldest Age Group

August 20th 2019

Cancers of the lung, breast, prostate, and colon are most common in adults aged 85 years and older.

Read More

Study Shows Colorectal Cancer Tumors May Metastasize Earlier Than Expected

Study Shows Colorectal Cancer Tumors May Metastasize Earlier Than Expected

June 19th 2019

Colon cancer may spread to other parts of the body before original tumors are clinically detectable.

Read More

<1234